These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7121935)

  • 1. Fracture frequency and bone preservation in postmenopausal women treated with estrogen.
    Jensen GF; Christiansen C; Transbøl I
    Obstet Gynecol; 1982 Oct; 60(4):493-6. PubMed ID: 7121935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalence.
    Wasnich RD; Ross PD; Heilbrun LK; Vogel JM; Yano K; Benfante RJ
    Obstet Gynecol; 1986 Apr; 67(4):457-62. PubMed ID: 3960416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal bone loss and estrogen replacement.
    Meema S; Meema HE
    Isr J Med Sci; 1976 Jul; 12(7):601-6. PubMed ID: 972014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of estrogen on postmenopausal bone loss.
    Meema S; Bunker ML; Meema HE
    Arch Intern Med; 1975 Nov; 135(11):1436-40. PubMed ID: 1190928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of postmenopausal spinal and long bone fractures. A unifying approach to postmenopausal osteoporosis.
    Jensen GF; Christiansen C; Boesen J; Hegedüs V; Transbøl I
    Clin Orthop Relat Res; 1982 Jun; (166):75-81. PubMed ID: 7083689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the menopause on ischaemic heart disease and its risk factors and on bone mineral content.
    Lindquist O
    Acta Obstet Gynecol Scand Suppl; 1982; 110():1-32. PubMed ID: 6957134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.
    Richelson LS; Wahner HW; Melton LJ; Riggs BL
    N Engl J Med; 1984 Nov; 311(20):1273-5. PubMed ID: 6493283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
    Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of bone mass in postmenopausal women.
    Aloia JF; Vaswani AN; Yeh JK; Ross P; Ellis K; Cohn SH
    Arch Intern Med; 1983 Sep; 143(9):1700-4. PubMed ID: 6615091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of grip strength change with menopausal bone loss and related fractures: a population-based follow-up study.
    Sirola J; Rikkonen T; Tuppurainen M; Jurvelin JS; Kröger H
    Calcif Tissue Int; 2006 Apr; 78(4):218-26. PubMed ID: 16604281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
    Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
    J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal changes in bone remodeling.
    Heaney RP; Recker RR; Saville PD
    J Lab Clin Med; 1978 Dec; 92(6):964-70. PubMed ID: 739174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years.
    Love RR; Barden HS; Mazess RB; Epstein S; Chappell RJ
    Arch Intern Med; 1994 Nov; 154(22):2585-8. PubMed ID: 7979855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between low lean body mass and osteoporotic fractures after menopause.
    Capozza RF; Cure-Cure C; Cointry GR; Meta M; Cure P; Rittweger J; Ferretti JL
    Menopause; 2008; 15(5):905-13. PubMed ID: 18520697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of number of pregnancies on bone mineral density in postmenopausal women of different age groups.
    Gur A; Nas K; Cevik R; Sarac AJ; Ataoglu S; Karakoc M
    J Bone Miner Metab; 2003; 21(4):234-41. PubMed ID: 12811629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the risk factors for osteoporosis among postmenopausal women.
    Demir B; Haberal A; Geyik P; Baskan B; Ozturkoglu E; Karacay O; Deveci S
    Maturitas; 2008; 60(3-4):253-6. PubMed ID: 18778903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.